A study to assess the safety of Anumigilimab in adults with sickle cell disease
- Substances:ANUMIGILIMAB
Belgium- Participants:18–64 years · 65+ years
- Substances:ANUMIGILIMAB
- Sponsor:CSL Behring LLC
Rare diseases
Investigational molecules
Locations
Back to Belgium507 clinical trials in Edegem, Belgium across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on viral infections and vaccine development, including studies for influenza, RSV, and COVID-19. Multiple trials are evaluating immune responses and vaccine efficacy in different age groups.
Special attention is given to vulnerable populations, including elderly adults and pregnant women.
Innovative studies addressing Primary Biliary Cholangitis and Hepatitis D treatments. Research includes evaluation of novel therapeutics and their impact on disease progression.
Trials focus on improving patient outcomes and developing targeted treatments.
Advanced research in breast cancer and lung cancer treatments, exploring new therapeutic combinations and targeted approaches for better patient outcomes.
Focus on personalized medicine approaches and innovative treatment combinations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.